Lupus Research Alliance collaborates with Bristol-Myers Squibb to study BMS-986165 for lupus April 27, 2018
Phase IIb/III rheumatoid arthritis study of upadacitinib in Japanese patients meets primary endpoint April 26, 2018
FDA advisory committee recommends baricitinib 2 mg, rejects 4-mg dose in rheumatoid arthritis April 24, 2018
Biogen and Samsung Bioepis cleared to commercialize Imraldi following AbbVie settlement April 6, 2018
RSS